Barrat; Franck

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barrat; Franck.The latest application filed is for "methods of treating cancer, infectious disease, and autoimmune disease using chemokines".

Company Profile

0.13.16

Barrat; Franck - New York NY
Barrat; Franck - San Francisco CA US
Barrat; Franck - San Mateo CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Cancer, Infectious Disease, And Autoimmune Disease Using Chemokines App 20220072100 - Barrat; Franck	2022-03-10
Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines Grant 11,197,890 - Barrat December 14, 2	2021-12-14
Methods Of Treating Cancer, Infectious Disease, And Autoimmune Disease Using Cxc Chemokines App 20180193382 - Barrat; Franck	2018-07-12
Human toll-like receptor inhibitors and methods of use thereof Grant 9,868,955 - Guiducci , et al. January 16, 2	2018-01-16
Methods and compositions for inhibition of immune responses and autoimmunity Grant 9,476,053 - Barrat , et al. October 25, 2	2016-10-25
Methods of treatment using TLR7 and/or TLR9 inhibitors Grant 9,347,064 - Barrat , et al. May 24, 2	2016-05-24
Tlr8 Transgenic Animals App 20160003807 - BARRAT; Franck ; et al.	2016-01-07
Human toll-like receptor inhibitors and methods of use thereof Grant 9,228,184 - Guiducci , et al. January 5, 2	2016-01-05
Methods And Compositions For Inhibition Of Immune Responses And Autoimmunity App 20150275216 - BARRAT; Franck ; et al.	2015-10-01
Human Toll-like Receptor Inhibitors And Methods Of Use Thereof App 20150252363 - Guiducci; Cristiana ; et al.	2015-09-10
Methods Of Treatment Using Tlr7 And/or Tlr9 Inhibitors App 20150203850 - BARRAT; Franck ; et al.	2015-07-23
Transgenic mice expressing human toll-like receptor 8 Grant 9,063,123 - Barrat , et al. June 23, 2	2015-06-23
Methods and compositions for inhibition of immune responses and autoimmunity Grant 8,962,579 - Barrat , et al. February 24, 2	2015-02-24
Methods And Compositions For Inhibition Of Innate Immune Responses And Autoimmunity App 20150050296 - BARRAT; Franck ; et al.	2015-02-19
Methods of treatment using TLR7 and/or TLR9 inhibitors Grant 8,940,310 - Barrat , et al. January 27, 2	2015-01-27
Methods and compositions for inhibition of innate immune responses and autoimmunity Grant 8,759,305 - Barrat , et al. June 24, 2	2014-06-24
Human Toll-like Receptor Inhibitors And Methods Of Use Thereof App 20140094504 - GUIDUCCI; Cristiana ; et al.	2014-04-03
Methods Of Treatment Using Tlr7 And/or Tlr9 Inhibitors App 20130156814 - Barrat; Franck ; et al.	2013-06-20
Tlr8 Transgenic Animals App 20120252051 - Barrat; Franck ; et al.	2012-10-04
Methods And Compositions For Induction Or Promotion Of Immune Tolerance App 20110123561 - BARRAT; Franck ; et al.	2011-05-26
Methods And Compositions For Inhibition Of Immune Responses And Autoimmunity App 20110003885 - BARRAT; FRANCK ; et al.	2011-01-06
Inhibition of type I in IFN production App 20090131512 - Barrat; Franck ; et al.	2009-05-21
Methods and compositions for inhibition of innate immune responses and autoimmunity App 20070238678 - Barrat; Franck ; et al.	2007-10-11
Methods and compositions for induction or promotion of immune tolerance App 20060193869 - Barrat; Franck ; et al.	2006-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.